News

StockStory.org on MSN7d
Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
StockStory.org on MSN7d
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug ...